Boryung Corporation (KRX:003850)
South Korea · Delayed Price · Currency is KRW 8,530.00
+100.00 (1.19%)
Last updated: Aug 14, 2025
Boryung Company Description
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs.
The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022.
Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Boryung Corporation
| Country | South Korea |
| Founded | 1957 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,533 |
| CEO | Jung-Gyun Kim |
Contact Details
Address: Boryeong Building Seoul, 03127 South Korea | |
| Phone | 82 2 708 8000 |
| Website | boryung.co.kr |
Stock Details
| Ticker Symbol | 003850 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003850005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Chang | Chief Executive Officer of Pharma Biz |
| Jung-Gyun Kim | Chairman and Chief Executive Officer |
| Young-Ha Kim | Senior Managing Director, Director of Marketing Division and Director |
| Ho-Young Baek | Director of Operation Support Division and Director |